SEC EDGAR published this disclosure on 2026-08-03. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001251779-26-000009
acquired disposedA
codeA
direct or indirectD
form4
is derivativefalse
issuer nameAltimmune, Inc.
labelGrant or award
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001251779-26-000009",
"acquired_disposed": "A",
"code": "A",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "Altimmune, Inc.",
"label": "Grant or award",
"person_name": "WEAVER GREGORY L",
"price": 2.414,
"role": "Chief Financial Officer",
"security": "Common Stock, par value $0.0001",
"shares": 1753,
"shares_owned_after": 39831,
"source_path": "edgar/data/1326190/0001251779-26-000009.txt",
"ticker": "ALT",
"value": 4231.742
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.